期刊文献+

胱抑素和血钠及血氨在早期判断慢加急性肝衰竭并发肝肾综合征中的价值 被引量:2

The value of cystatin,blood sodium and blood ammonia in early diagnosis of acute liver failure complicated with hepatorenal syndrome
下载PDF
导出
摘要 目的:探讨胱抑素(Cys-C)、血钠、血氨在早期判断慢加急性肝衰竭并发肝肾综合征(HRS)中的价值。方法:选择2018年5月—2019年5月就诊的慢加急性肝功能衰竭患者60例,将其按是否并发HRS分为慢加急性肝衰竭并发HRS组(HRS组)和慢加急性肝衰竭未并发HRS组(非HRS组),收集各组病例肝功能、肾功能(Cys-C)、凝血功能、血氨、电解质等数据,分析各组差异以及Cys-C,Na,NH^3+与HRS的关系。结果:HRS组Cys-C,Na,NH^3+水平明显较非HRS组高(P<0.05);HRS组总胆红素(TBIL)、白蛋白(ALB)、国际标准化比值(INR)水平明显较非HRS组高(P<0.05);Cys-C,Na,NH^3+三个指标之间,两两均成正相关关系(P<0.05)。结论:Cys-C、血钠、血氨水平与慢加急性肝衰竭患者是否并发肝肾综合征密切相关,在早期判断慢加急性肝衰竭并发肝肾综合征中具有一定临床价值。 Objective:To investigate the value of cystatin(Cys-C),serum sodium and serum ammonia in early diagnosis of chronic acute liver failure complicated with hepatorenal syndrome.Methods:Sixty patients with chronic acute liver failure who were treated from May 2018 to May 2019 were selected.According to the diagnosis basis of hepatorenal syndrome,it was divided into chronic acute liver failure complicated with HRS group(HRS group)and slow acute liver failure without HRS group(non-HRS group).The data of liver function,renal function(Cys-C),coagulation function,blood ammonia,electrolytes were collected from each group.The differences between groups and the relationship between Cys-C,Na,NH^3+ and HRS were analyzed.Results:There was no significant difference in gender and age between the two groups(P>0.05).The mean age of the HRS group was significantly higher than that of the non-hrs group(P<0.05).The levels of Cys-C,Na and NH^3+ in HRS group were significantly higher than those in non-hrs group(P<0.05).Total bilirubin(TBIL),albumin(ALB)and international normalized ratio(INR)levels were significantly higher in the HRS group than in the non-hrs group(P<0.05).There was a positive correlation between Cys-C,Na and NH^3+(P<0.05).Conclusion:The levels of Cys-C,serum sodium and serum ammonia are closely related to the complications of liver-kidney syndrome in patients with chronic acute liver failure,and have certain clinical value in early judgment of the complications of chronic acute liver failure with liver-kidney syndrome.
作者 刘娟 LIU Juan(Ganzhou People′s Hospital,Ganzhou 341000,China)
机构地区 赣州市人民医院
出处 《临床医药实践》 2020年第2期93-96,共4页 Proceeding of Clinical Medicine
基金 江西省卫生计生委科技计划项目(项目编号:20184063)
关键词 慢加急性肝衰竭 肝肾综合征 血钠 血氨 胱抑素 chronic acute liver failure hepatorenal syndrome serum sodium serum ammonia cystatin
  • 相关文献

参考文献10

二级参考文献52

  • 1George N Kalambokis,Konstantinos Pappas,Epameinondas V Tsianos.Terlipressin improves pulmonary pressures in cirrhotic patients with pulmonary hypertension and variceal bleeding or hepatorenal syndrome[J].Hepatobiliary & Pancreatic Diseases International,2012,11(4):434-437. 被引量:4
  • 2Zhi-Hong Wan,Jian-Jun Wang,Shao-Li You,Hong-Ling Liu,Bing Zhu,Hong Zang,Chen Li,Jing Chen,Shao-Jie Xin.Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure[J].World Journal of Gastroenterology,2013,19(48):9432-9438. 被引量:21
  • 3Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 4Wong F.Hepatorenalsyndrome:currentmanagement.Curr Gastroenterol Rep,2008,10:22-29.
  • 5Angeli P,Merkel C.Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis.J Hepatol,2008,48:S93-S103.
  • 6Salerno F,Gerbes A,Gines P,et al.Diagnosis,prevention and treatment of hepatorenal syndrome with cirrhosis.Gut,2007,56:1310-1318.
  • 7Angemayr B,Ceina M,Karnel F,et al.Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemie shunt.Gut,2003,52:879-885.
  • 8C(a)rdenas A,Gines P.Hepatorenal syndrome.Clin Liver Dis,2006,10:371-385.
  • 9Krag A,Bendtsen F,Henriksen JH,et al.Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites.Gut,2010,59:105-110.
  • 10Wong F,Raina N,Richardson R.Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.Gut,2010,59:381-386.

共引文献62

同被引文献30

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部